Benzocaine
Benzocaine - Related Videos
11:24
A Time Differential Staining Technique Coupled with Full Bilateral Gill Denervation to Study Ionocytes in Fish
0 Views •
Cited by 1 •
2015
This manuscript describes a protocol to track the re-distribution of branchial ionocytes and their innervation using a time differential staining technique coupled with full bilateral gill denervation.
07:23
Electroporation of Craniofacial Mesenchyme
0 Views •
2011
Craniofacial cartilages develop in close contact with other tissues and are difficult to manipulate in live animals. We are using electroporation to deliver molecular tools during growth of the craniofacial skeleton while bypassing early embryonic effects. This approach will allow us to efficiently test candidate molecules in vivo.
08:11
Complete Spinal Cord Injury and Brain Dissection Protocol for Subsequent Wholemount In Situ Hybridization in Larval Sea Lamprey
0 Views •
Cited by 18 •
2014
Lampreys recover locomotion after a complete spinal cord injury. However, some spinal-projecting neurons are good regenerators and others are not. This paper illustrates the techniques for housing sea lamprey larvae (and recently transformed adults), producing complete spinal cord transections and preparing wholemount brains and spinal cords for in situ hybridization.
11:29
Technique to Target Microinjection to the Developing Xenopus Kidney
0 Views •
Cited by 17 •
2016
Here, we present a protocol to use fate maps and lineage tracers to target injections into individual blastomeres that give rise to the kidney of Xenopus laevis embryos.
FAQs
After entering nerve membranes, benzocaine reversibly blocks voltage-gated sodium channels. These channels normally support the initiation and conduction of action potentials, which are electrical signals in sensory neurons. By interrupting that signaling process, the drug reduces the ability of affected peripheral nerves to transmit pain and other sensations from the application site.
Benzocaine is poorly water-soluble, so it mainly remains near the site where it is applied rather than distributing broadly from that location. This property supports localized action on nearby peripheral nerves. Consequently, creams, sprays, gels, and lozenges can target limited areas of skin or mucous membrane instead of producing a generalized reduction in sensation.
The block is reversible, meaning the affected voltage-gated sodium channels are not permanently disabled. As the local effect subsides, sensory neurons can again initiate and conduct action potentials. This reversibility explains why benzocaine reduces sensation only temporarily and why normal sensory signaling can return after the localized pharmacologic effect ends.
Benzocaine is used for localized relief because its poor water solubility and tendency to remain at the application site limit the area of action. Its pharmacologic effect is therefore concentrated in nearby peripheral nerves. This contrasts with an approach intended to alter sensation broadly, although the provided information does not specify another anesthetic or systemic method for direct comparison.
The available formulations described for benzocaine include creams, sprays, gels, and lozenges. These forms support application to localized areas of skin or mucous membranes, depending on where discomfort occurs. In pharmacology, their relevance lies in delivering the anesthetic at the site of minor pain, irritation, or oral and throat discomfort.
Excessive benzocaine exposure can rarely cause methemoglobinemia, a clinically important safety concern. This risk is relevant because the drug is intended for localized use, where its effect remains mainly near the application site. Pharmacologic evaluation should therefore consider not only the desired temporary reduction in sensation but also the consequences of excessive exposure.